EU Pharmacovigilance legislation implementation likely to be staggered
This article was originally published in Scrip
Executive Summary
As the European Medicines Agency struggles to finance implementing the far reaching pharmacovigilance legislation, it looks as if the new requirements will be introduced in phases beyond the original July 2012 implementation deadline, confirmed Peter Arlett, head of pharmacovigilance and risk management at the European Medicines Agency.